ICD-10-CM Billable Code

C51.2

Malignant neoplasm of clitoris

Clinical Classification Guidelines

Medical Intelligence & Overview

Malignant neoplasm of the clitoris, classified under ICD-10 code C51.2, is a rare form of cancer that originates in the tissues of the clitoris. As a part of the female genital organs, the clitoris is not only vital for sexual arousal but can also be affected by various medical conditions, including rare instances of cancer. Recognizing and understanding this condition is crucial for timely diagnosis and management.

Causes & Symptoms

Clinical Causes: Genetic mutations leading to abnormal cell growth Chronic inflammation or irritation of the clitoral tissue Human papillomavirus (HPV) infection, which is associated with some genital cancers History of other gynecological cancers Exposure to carcinogenic substances or environmental factors

Key Symptoms: A noticeable lump or mass on or near the clitoris Persistent pain or discomfort in the genital area Ulceration or open sore that does not heal Bleeding from the clitoral area unrelated to menstrual cycles Swelling or enlargement of the clitoris Changes in skin texture or color in the affected area Unexplained weight loss or fatigue in advanced cases

Diagnostic & Treatment

Diagnosis Path: Diagnosing a malignant neoplasm of the clitoris involves several steps: - Physical examination to assess any visible or palpable abnormalities - Imaging studies such as ultrasound, MRI, or CT scans to evaluate the extent of the tumor - Biopsy of the suspicious tissue to confirm cancerous cells - Additional tests like pelvic exams and laboratory assessments to rule out metastasis and assess overall health A multidisciplinary approach is often employed to determine the stage and plan effective treatment strategies.

Treatment Protocols: Management of malignant neoplasm of the clitoris typically includes: - Surgical removal of the tumor, which may involve partial or complete removal of the clitoris and surrounding tissues - Radiation therapy to target residual cancer cells - Chemotherapy, particularly in advanced cases or when the cancer has spread - Targeted therapy or immunotherapy may be considered in certain cases based on specific tumor characteristics - Supportive care to address symptoms and maintain quality of life Each treatment plan is tailored to the individual’s health status, stage of the tumor, and personal considerations. Prevention strategies focus on reducing risk factors such as HPV vaccination and regular gynecological examinations, which can aid early detection and improve outcomes.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C51.2 a billable ICD-10 code?
Yes, C51.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C51.2?
Clinical documentation must specify the nature of Malignant neoplasm of clitoris and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

clitoris neoplasm malignant